Catecholestrogens induce oxidative stress and malignant transformation in human endometrial glandular cells

Protective effect of catechol-O- methyltransferase

Salama A. Salama, Marwa Kamel, Mohamed Awad, Abdel Hakim Ben Nasser, Ayman Al-Hendy, Shaleen Botting, Concepcion Arrastia

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Prolonged exposure to unopposed estrogens is a major risk factor for the development of endometrial cancer. Oxidative metabolism of estradiol (E 2) into the catecholestrogens (CEs), 4-hydroxyestradiol (4-OHE 2) and 2-hydroxyestradiol (2-OHE2), may play an important role in estrogen carcinogenicity. CEs can be oxidized to the corresponding ortho-quinone derivatives with concomitant formation of the reactive oxygen species (ROS). Catechol-O-methyltransferase (COMT) is the major enzyme involved in the detoxification of CEs in extrahepatic tissues. We investigated the potential of E2, 2-OHE2 and 4-OHE2 to induce microsatellite instability (MSI) and neoplastic transformation of immortalized human endometrial glandular (EM) cells. We also investigated the functional significance of COMT gene expression on modulating the effects of E2 and CEs in EM cells. Our data indicated that E2 and 4-OHE2 induce MSI, ROS and neoplastic transformation in EM cells. The capacity of E2 and its catechol metabolites to induce MSI, ROS and neoplastic transformation in EM cells is ranked as follows: 4-OHE2 > E 2 > 2-OHE2. Knockdown of COMT expression in EM cells resulted in increased estrogenic milieu and increased estrogen-induced cell proliferation. More importantly, knockdown of COMT increased the propensity of E2 or CEs to induce ROS, MSI and neoplastic transformation of EM cells. In contrast, overexpression of COMT in EM cells significantly reduced the cellular estrogenic milieu and protected against E2- or CEs-induced, ROS, MSI and neoplastic transformation. The capacity of E2 or CEs to induce neoplastic transformation of human endometrial glandular cells in vitro may suggest that E2-induced endometrial cancer is mediated by its metabolism into CEs. Our study clearly indicates that COMT gene expression plays a critical role in modulating the hormonal and carcinogenic effects of E 2 and CEs and, consequently, modifies the risk for E 2-induced endometrial cancer. To the best of our knowledge, this is the first study to (i) demonstrate the potential capacity of estrogen and its catechol metabolites to induce neoplastic transformation of immortalized human endometrial glandular cells; and (ii) illustrate the important role of COMT gene expression in protecting against E2-induced endometrial cancer.

Original languageEnglish (US)
Pages (from-to)1246-1254
Number of pages9
JournalInternational Journal of Cancer
Volume123
Issue number6
DOIs
StatePublished - Sep 15 2008

Fingerprint

Catechol Estrogens
Catechol O-Methyltransferase
Oxidative Stress
Microsatellite Instability
Reactive Oxygen Species
Endometrial Neoplasms
Estrogens
Gene Expression
Estradiol

Keywords

  • COMT
  • Catecholestrogens
  • Endometrial cancer
  • Genomic instability

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Catecholestrogens induce oxidative stress and malignant transformation in human endometrial glandular cells : Protective effect of catechol-O- methyltransferase. / Salama, Salama A.; Kamel, Marwa; Awad, Mohamed; Nasser, Abdel Hakim Ben; Al-Hendy, Ayman; Botting, Shaleen; Arrastia, Concepcion.

In: International Journal of Cancer, Vol. 123, No. 6, 15.09.2008, p. 1246-1254.

Research output: Contribution to journalArticle

Salama, Salama A. ; Kamel, Marwa ; Awad, Mohamed ; Nasser, Abdel Hakim Ben ; Al-Hendy, Ayman ; Botting, Shaleen ; Arrastia, Concepcion. / Catecholestrogens induce oxidative stress and malignant transformation in human endometrial glandular cells : Protective effect of catechol-O- methyltransferase. In: International Journal of Cancer. 2008 ; Vol. 123, No. 6. pp. 1246-1254.
@article{115ebc370d91499d82924004ef048f58,
title = "Catecholestrogens induce oxidative stress and malignant transformation in human endometrial glandular cells: Protective effect of catechol-O- methyltransferase",
abstract = "Prolonged exposure to unopposed estrogens is a major risk factor for the development of endometrial cancer. Oxidative metabolism of estradiol (E 2) into the catecholestrogens (CEs), 4-hydroxyestradiol (4-OHE 2) and 2-hydroxyestradiol (2-OHE2), may play an important role in estrogen carcinogenicity. CEs can be oxidized to the corresponding ortho-quinone derivatives with concomitant formation of the reactive oxygen species (ROS). Catechol-O-methyltransferase (COMT) is the major enzyme involved in the detoxification of CEs in extrahepatic tissues. We investigated the potential of E2, 2-OHE2 and 4-OHE2 to induce microsatellite instability (MSI) and neoplastic transformation of immortalized human endometrial glandular (EM) cells. We also investigated the functional significance of COMT gene expression on modulating the effects of E2 and CEs in EM cells. Our data indicated that E2 and 4-OHE2 induce MSI, ROS and neoplastic transformation in EM cells. The capacity of E2 and its catechol metabolites to induce MSI, ROS and neoplastic transformation in EM cells is ranked as follows: 4-OHE2 > E 2 > 2-OHE2. Knockdown of COMT expression in EM cells resulted in increased estrogenic milieu and increased estrogen-induced cell proliferation. More importantly, knockdown of COMT increased the propensity of E2 or CEs to induce ROS, MSI and neoplastic transformation of EM cells. In contrast, overexpression of COMT in EM cells significantly reduced the cellular estrogenic milieu and protected against E2- or CEs-induced, ROS, MSI and neoplastic transformation. The capacity of E2 or CEs to induce neoplastic transformation of human endometrial glandular cells in vitro may suggest that E2-induced endometrial cancer is mediated by its metabolism into CEs. Our study clearly indicates that COMT gene expression plays a critical role in modulating the hormonal and carcinogenic effects of E 2 and CEs and, consequently, modifies the risk for E 2-induced endometrial cancer. To the best of our knowledge, this is the first study to (i) demonstrate the potential capacity of estrogen and its catechol metabolites to induce neoplastic transformation of immortalized human endometrial glandular cells; and (ii) illustrate the important role of COMT gene expression in protecting against E2-induced endometrial cancer.",
keywords = "COMT, Catecholestrogens, Endometrial cancer, Genomic instability",
author = "Salama, {Salama A.} and Marwa Kamel and Mohamed Awad and Nasser, {Abdel Hakim Ben} and Ayman Al-Hendy and Shaleen Botting and Concepcion Arrastia",
year = "2008",
month = "9",
day = "15",
doi = "10.1002/ijc.23653",
language = "English (US)",
volume = "123",
pages = "1246--1254",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Catecholestrogens induce oxidative stress and malignant transformation in human endometrial glandular cells

T2 - Protective effect of catechol-O- methyltransferase

AU - Salama, Salama A.

AU - Kamel, Marwa

AU - Awad, Mohamed

AU - Nasser, Abdel Hakim Ben

AU - Al-Hendy, Ayman

AU - Botting, Shaleen

AU - Arrastia, Concepcion

PY - 2008/9/15

Y1 - 2008/9/15

N2 - Prolonged exposure to unopposed estrogens is a major risk factor for the development of endometrial cancer. Oxidative metabolism of estradiol (E 2) into the catecholestrogens (CEs), 4-hydroxyestradiol (4-OHE 2) and 2-hydroxyestradiol (2-OHE2), may play an important role in estrogen carcinogenicity. CEs can be oxidized to the corresponding ortho-quinone derivatives with concomitant formation of the reactive oxygen species (ROS). Catechol-O-methyltransferase (COMT) is the major enzyme involved in the detoxification of CEs in extrahepatic tissues. We investigated the potential of E2, 2-OHE2 and 4-OHE2 to induce microsatellite instability (MSI) and neoplastic transformation of immortalized human endometrial glandular (EM) cells. We also investigated the functional significance of COMT gene expression on modulating the effects of E2 and CEs in EM cells. Our data indicated that E2 and 4-OHE2 induce MSI, ROS and neoplastic transformation in EM cells. The capacity of E2 and its catechol metabolites to induce MSI, ROS and neoplastic transformation in EM cells is ranked as follows: 4-OHE2 > E 2 > 2-OHE2. Knockdown of COMT expression in EM cells resulted in increased estrogenic milieu and increased estrogen-induced cell proliferation. More importantly, knockdown of COMT increased the propensity of E2 or CEs to induce ROS, MSI and neoplastic transformation of EM cells. In contrast, overexpression of COMT in EM cells significantly reduced the cellular estrogenic milieu and protected against E2- or CEs-induced, ROS, MSI and neoplastic transformation. The capacity of E2 or CEs to induce neoplastic transformation of human endometrial glandular cells in vitro may suggest that E2-induced endometrial cancer is mediated by its metabolism into CEs. Our study clearly indicates that COMT gene expression plays a critical role in modulating the hormonal and carcinogenic effects of E 2 and CEs and, consequently, modifies the risk for E 2-induced endometrial cancer. To the best of our knowledge, this is the first study to (i) demonstrate the potential capacity of estrogen and its catechol metabolites to induce neoplastic transformation of immortalized human endometrial glandular cells; and (ii) illustrate the important role of COMT gene expression in protecting against E2-induced endometrial cancer.

AB - Prolonged exposure to unopposed estrogens is a major risk factor for the development of endometrial cancer. Oxidative metabolism of estradiol (E 2) into the catecholestrogens (CEs), 4-hydroxyestradiol (4-OHE 2) and 2-hydroxyestradiol (2-OHE2), may play an important role in estrogen carcinogenicity. CEs can be oxidized to the corresponding ortho-quinone derivatives with concomitant formation of the reactive oxygen species (ROS). Catechol-O-methyltransferase (COMT) is the major enzyme involved in the detoxification of CEs in extrahepatic tissues. We investigated the potential of E2, 2-OHE2 and 4-OHE2 to induce microsatellite instability (MSI) and neoplastic transformation of immortalized human endometrial glandular (EM) cells. We also investigated the functional significance of COMT gene expression on modulating the effects of E2 and CEs in EM cells. Our data indicated that E2 and 4-OHE2 induce MSI, ROS and neoplastic transformation in EM cells. The capacity of E2 and its catechol metabolites to induce MSI, ROS and neoplastic transformation in EM cells is ranked as follows: 4-OHE2 > E 2 > 2-OHE2. Knockdown of COMT expression in EM cells resulted in increased estrogenic milieu and increased estrogen-induced cell proliferation. More importantly, knockdown of COMT increased the propensity of E2 or CEs to induce ROS, MSI and neoplastic transformation of EM cells. In contrast, overexpression of COMT in EM cells significantly reduced the cellular estrogenic milieu and protected against E2- or CEs-induced, ROS, MSI and neoplastic transformation. The capacity of E2 or CEs to induce neoplastic transformation of human endometrial glandular cells in vitro may suggest that E2-induced endometrial cancer is mediated by its metabolism into CEs. Our study clearly indicates that COMT gene expression plays a critical role in modulating the hormonal and carcinogenic effects of E 2 and CEs and, consequently, modifies the risk for E 2-induced endometrial cancer. To the best of our knowledge, this is the first study to (i) demonstrate the potential capacity of estrogen and its catechol metabolites to induce neoplastic transformation of immortalized human endometrial glandular cells; and (ii) illustrate the important role of COMT gene expression in protecting against E2-induced endometrial cancer.

KW - COMT

KW - Catecholestrogens

KW - Endometrial cancer

KW - Genomic instability

UR - http://www.scopus.com/inward/record.url?scp=49749104328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49749104328&partnerID=8YFLogxK

U2 - 10.1002/ijc.23653

DO - 10.1002/ijc.23653

M3 - Article

VL - 123

SP - 1246

EP - 1254

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 6

ER -